ABUS logo

Arbutus Biopharma (ABUS) Operating profit

annual operating profit:

-$69.97M+$8.06M(+10.33%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ABUS annual operating income is -$69.97 million, with the most recent change of +$8.06 million (+10.33%) on December 31, 2024.
  • During the last 3 years, ABUS annual operating profit has risen by +$1.68 million (+2.34%).
  • ABUS annual operating profit is now -310.02% below its all-time high of $33.32 million, reached on December 31, 2012.

Performance

ABUS Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

quarterly operating profit:

-$13.03M-$1.08M(-9.03%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ABUS quarterly operating income is -$13.03 million, with the most recent change of -$1.08 million (-9.03%) on March 31, 2025.
  • Over the past year, ABUS quarterly operating profit has increased by +$6.16 million (+32.09%).
  • ABUS quarterly operating profit is now -132.23% below its all-time high of $40.42 million, reached on December 31, 2012.

Performance

ABUS quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

TTM operating profit:

-$63.82M+$6.16M(+8.80%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ABUS TTM operating income is -$63.82 million, with the most recent change of +$6.16 million (+8.80%) on March 31, 2025.
  • Over the past year, ABUS TTM operating profit has increased by +$16.26 million (+20.30%).
  • ABUS TTM operating profit is now -290.86% below its all-time high of $33.44 million, reached on December 31, 2012.

Performance

ABUS TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABUSincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

ABUS Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+10.3%+32.1%+20.3%
3 y3 years+2.3%-20.9%+4.6%
5 y5 years+1.9%-0.4%+2.4%

ABUS Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-10.7%+10.3%-20.9%+39.0%-1.6%+22.6%
5 y5-year-22.2%+10.3%-20.9%+39.0%-17.6%+22.6%
alltimeall time-310.0%+30.2%-132.2%+66.5%-290.9%+36.4%

ABUS Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
-$13.03M(+9.0%)
-$63.82M(-8.8%)
Dec 2024
-$69.97M(-10.3%)
-$11.95M(-31.6%)
-$69.97M(-10.9%)
Sep 2024
-
-$17.47M(-18.3%)
-$78.55M(-4.7%)
Jun 2024
-
-$21.37M(+11.4%)
-$82.43M(+2.9%)
Mar 2024
-
-$19.18M(-6.5%)
-$80.08M(+2.6%)
Dec 2023
-$78.03M(+23.4%)
-$20.52M(-3.9%)
-$78.03M(-0.6%)
Sep 2023
-
-$21.35M(+12.3%)
-$78.47M(+5.0%)
Jun 2023
-
-$19.02M(+11.0%)
-$74.71M(+7.4%)
Mar 2023
-
-$17.14M(-18.2%)
-$69.59M(+10.1%)
Dec 2022
-$63.22M(-11.8%)
-$20.95M(+19.1%)
-$63.22M(+0.6%)
Sep 2022
-
-$17.60M(+26.6%)
-$62.87M(+0.1%)
Jun 2022
-
-$13.90M(+29.0%)
-$62.83M(-6.1%)
Mar 2022
-
-$10.77M(-47.7%)
-$66.88M(-6.7%)
Dec 2021
-$71.65M(+25.1%)
-$20.60M(+17.4%)
-$71.65M(+6.6%)
Sep 2021
-
-$17.55M(-2.2%)
-$67.22M(+3.8%)
Jun 2021
-
-$17.95M(+15.4%)
-$64.77M(+8.2%)
Mar 2021
-
-$15.55M(-3.9%)
-$59.84M(+4.5%)
Dec 2020
-$57.27M(-19.7%)
-$16.18M(+7.1%)
-$57.27M(+5.5%)
Sep 2020
-
-$15.10M(+16.0%)
-$54.28M(-5.8%)
Jun 2020
-
-$13.02M(+0.3%)
-$57.61M(-11.9%)
Mar 2020
-
-$12.98M(-1.6%)
-$65.37M(-8.4%)
Dec 2019
-$71.34M(+1.7%)
-$13.18M(-28.4%)
-$71.34M(-3.6%)
Sep 2019
-
-$18.43M(-11.3%)
-$73.98M(+0.4%)
Jun 2019
-
-$20.78M(+9.6%)
-$73.66M(+1.8%)
Mar 2019
-
-$18.95M(+19.8%)
-$72.34M(+3.1%)
Dec 2018
-$70.17M(+0.1%)
-$15.82M(-12.7%)
-$70.17M(-4.9%)
Sep 2018
-
-$18.11M(-7.0%)
-$73.81M(+7.6%)
Jun 2018
-
-$19.46M(+16.0%)
-$68.60M(-0.0%)
Mar 2018
-
-$16.78M(-13.7%)
-$68.62M(-2.2%)
Dec 2017
-$70.13M(-30.1%)
-$19.45M(+50.8%)
-$70.13M(-4.1%)
Sep 2017
-
-$12.90M(-33.8%)
-$73.10M(-7.7%)
Jun 2017
-
-$19.48M(+6.5%)
-$79.17M(-19.7%)
Mar 2017
-
-$18.30M(-18.4%)
-$98.61M(-1.7%)
Dec 2016
-$100.29M(+81.5%)
-$22.42M(+18.1%)
-$100.29M(+11.2%)
Sep 2016
-
-$18.98M(-51.3%)
-$90.21M(-1.3%)
Jun 2016
-
-$38.92M(+94.8%)
-$91.39M(+37.4%)
Mar 2016
-
-$19.98M(+61.9%)
-$66.52M(+20.4%)
Dec 2015
-$55.26M
-$12.34M(-38.8%)
-$55.26M(+3.0%)
Sep 2015
-
-$20.15M(+43.3%)
-$53.66M(+33.0%)
Jun 2015
-
-$14.06M(+61.4%)
-$40.36M(+13.0%)
DateAnnualQuarterlyTTM
Mar 2015
-
-$8.71M(-18.9%)
-$35.73M(+8.3%)
Dec 2014
-$32.97M(+171.3%)
-$10.75M(+57.0%)
-$32.97M(+33.7%)
Sep 2014
-
-$6.84M(-27.4%)
-$24.66M(+14.9%)
Jun 2014
-
-$9.42M(+58.2%)
-$21.47M(+42.0%)
Mar 2014
-
-$5.96M(+144.6%)
-$15.12M(+24.4%)
Dec 2013
-$12.15M(-136.5%)
-$2.44M(-33.3%)
-$12.15M(-139.6%)
Sep 2013
-
-$3.65M(+18.9%)
$30.70M(-5.7%)
Jun 2013
-
-$3.07M(+2.6%)
$32.55M(-1.6%)
Mar 2013
-
-$2.99M(-107.4%)
$33.08M(-1.1%)
Dec 2012
$33.32M(-411.6%)
$40.42M(-2343.5%)
$33.44M(-448.4%)
Sep 2012
-
-$1.80M(-29.0%)
-$9.60M(+1.9%)
Jun 2012
-
-$2.54M(-3.9%)
-$9.42M(-11.3%)
Mar 2012
-
-$2.64M(+0.9%)
-$10.62M(-4.7%)
Dec 2011
-$10.69M(+62.1%)
-$2.62M(+61.4%)
-$11.14M(+130.8%)
Sep 2011
-
-$1.62M(-56.7%)
-$4.83M(-14.0%)
Jun 2011
-
-$3.74M(+18.2%)
-$5.62M(+0.5%)
Mar 2011
-
-$3.17M(-185.6%)
-$5.59M(-14.9%)
Dec 2010
-$6.60M(-18.5%)
$3.70M(-253.4%)
-$6.57M(-44.3%)
Sep 2010
-
-$2.41M(-35.1%)
-$11.79M(-0.1%)
Jun 2010
-
-$3.71M(-10.4%)
-$11.80M(+17.9%)
Mar 2010
-
-$4.14M(+171.8%)
-$10.01M(+31.5%)
Dec 2009
-$8.10M(-3.0%)
-$1.52M(-37.0%)
-$7.61M(+26.1%)
Sep 2009
-
-$2.42M(+26.1%)
-$6.04M(-3.7%)
Jun 2009
-
-$1.92M(+10.0%)
-$6.27M(-33.8%)
Mar 2009
-
-$1.75M(-3389.6%)
-$9.47M(+10.6%)
Dec 2008
-$8.34M(-416.1%)
$53.10K(-102.0%)
-$8.56M(+0.4%)
Sep 2008
-
-$2.65M(-48.3%)
-$8.53M(+101.7%)
Jun 2008
-
-$5.12M(+508.8%)
-$4.23M(-493.1%)
Mar 2008
-
-$841.60K(-1082.0%)
$1.08M(-43.9%)
Dec 2007
$2.64M(-41.4%)
$85.70K(-94.8%)
$1.92M(+4.7%)
Sep 2007
-
$1.65M(+809.3%)
$1.83M(+909.3%)
Jun 2007
-
$181.50K
$181.50K
Dec 2006
$4.50M(-514.2%)
-
-
Dec 2005
-$1.09M(-95.3%)
-
-
Dec 2004
-$23.38M(-32.5%)
-
-
Dec 2003
-$34.65M(+44.7%)
-
-
Dec 2002
-$23.95M(+45.2%)
-
-
Dec 2001
-$16.49M(+53.5%)
-
-
Dec 2000
-$10.74M(+31.5%)
-
-
Dec 1999
-$8.17M(-6.6%)
-
-
Dec 1998
-$8.75M
-
-

FAQ

  • What is Arbutus Biopharma annual operating income?
  • What is the all time high annual operating profit for Arbutus Biopharma?
  • What is Arbutus Biopharma annual operating profit year-on-year change?
  • What is Arbutus Biopharma quarterly operating income?
  • What is the all time high quarterly operating profit for Arbutus Biopharma?
  • What is Arbutus Biopharma quarterly operating profit year-on-year change?
  • What is Arbutus Biopharma TTM operating income?
  • What is the all time high TTM operating profit for Arbutus Biopharma?
  • What is Arbutus Biopharma TTM operating profit year-on-year change?

What is Arbutus Biopharma annual operating income?

The current annual operating profit of ABUS is -$69.97M

What is the all time high annual operating profit for Arbutus Biopharma?

Arbutus Biopharma all-time high annual operating income is $33.32M

What is Arbutus Biopharma annual operating profit year-on-year change?

Over the past year, ABUS annual operating income has changed by +$8.06M (+10.33%)

What is Arbutus Biopharma quarterly operating income?

The current quarterly operating profit of ABUS is -$13.03M

What is the all time high quarterly operating profit for Arbutus Biopharma?

Arbutus Biopharma all-time high quarterly operating income is $40.42M

What is Arbutus Biopharma quarterly operating profit year-on-year change?

Over the past year, ABUS quarterly operating income has changed by +$6.16M (+32.09%)

What is Arbutus Biopharma TTM operating income?

The current TTM operating profit of ABUS is -$63.82M

What is the all time high TTM operating profit for Arbutus Biopharma?

Arbutus Biopharma all-time high TTM operating income is $33.44M

What is Arbutus Biopharma TTM operating profit year-on-year change?

Over the past year, ABUS TTM operating income has changed by +$16.26M (+20.30%)
On this page